Racura Oncology Ltd (ASX:RAC)
1.680
-0.010 (-0.59%)
Nov 17, 2026, 11:09 AM AEDT
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 329.4 million as of November 16, 2026. It is the 19,878th most valuable company in the world and the 376th biggest in Australia. Its market cap has decreased by 43.31% in one year.
Market Cap
329.40M
Enterprise Value
295.11M
Revenue
2.81M
Global Rank
Country Rank
#376 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 329.40M, an increase of 2,506.56%. That is a compound annual growth rate of 37.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 329.40M | -33.27% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 677.14M |
| Clinuvel Pharmaceuticals | 374.18M |
| Tetratherix | 339.57M |
| Starpharma Holdings | 203.89M |
| BLS Pharmaceuticals | 196.91M |
| Actinogen Medical | 173.15M |
| Paradigm Biopharmaceuticals | 153.48M |
| Orthocell | 152.54M |